Aditum Bio
Sandip Datta is a seasoned medical professional with extensive experience in immunology and infectious diseases. Currently serving as Vice President of Medical at Aditum Bio, Sandip Datta previously held significant roles at The Janssen Pharmaceutical Companies of Johnson & Johnson, including Senior Director and Head of Immunodermatology within Translational Sciences and Senior Director for Early Development in Infectious Diseases. Prior experience includes Clinical Director and Principal Scientist for Translational Pharmacology at Merck Research Laboratories and Head of the Bacterial Pathogenesis Unit at NIH/NIAID. Sandip Datta began an academic career as an Assistant Professor at the University of California, San Diego. Academic credentials include a Doctor of Medicine (M.D.) from the University of California, San Francisco, and a Bachelor of Science in Biochemistry from California Polytechnic State University-San Luis Obispo.
This person is not in any teams
This person is not in any offices
Aditum Bio
Aditum Bio is an investment fund that specializes in acquiring and developing pharmaceutical assets. It gives patients access to medicines that may not otherwise be developed. Aditum Bio was founded on 2019 and is headquartered in San Francisco, California.